Access the full text.
Sign up today, get DeepDyve free for 14 days.
E. Lange, P. Ravenstijn, D. Groenendaal, T. Steeg (2005)
Toward the prediction of CNS drug-effect profiles in physiological and pathological conditions using microdialysis and mechanism-based pharmacokinetic-pharmacodynamic modelingThe AAPS Journal, 7
K. Ward, B. Smith (2004)
A comprehensive quantitative and qualitative evaluation of extrapolation of intravenous pharmacokinetic parameters from rat, dog, and monkey to humans. I. Clearance.Drug metabolism and disposition: the biological fate of chemicals, 32 6
A. Bernareggi, M. Rowland (1991)
Physiologic modeling of cyclosporin kinetics in rat and manJournal of Pharmacokinetics and Biopharmaceutics, 19
P. Poulin, F. Theil (2000)
A priori prediction of tissue:plasma partition coefficients of drugs to facilitate the use of physiologically-based pharmacokinetic models in drug discovery.Journal of pharmaceutical sciences, 89 1
M. Andersen, H. Clewell, M. Reddy, Raymond Yang (2005)
Physiologically Based Pharmacokinetic Modeling : Science and Applications
T. Kararli (1995)
Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animalsBiopharmaceutics & Drug Disposition, 16
G. Caldwell, J. Masucci, Zhengyin Yan, W. Hageman (2004)
Allometric scaling of pharmacokinetic parameters in drug discovery: Can human CL, Vss and t1/2 be predicted fromin-vivo rat data?European Journal of Drug Metabolism and Pharmacokinetics, 29
H. Fischer (2005)
Towards quantitative biology: integration of biological information to elucidate disease pathways and to guide drug discovery.Biotechnology annual review, 11
A. Mirfazaelian, Kyu-Bong Kim, S. Anand, Hyo Kim, R. Tornero-Velez, J. Bruckner, J. Fisher (2006)
Development of a physiologically based pharmacokinetic model for deltamethrin in the adult male Sprague-Dawley rat.Toxicological sciences : an official journal of the Society of Toxicology, 93 2
T. Peters (2005)
Do Preclinical Testing Strategies Help Predict Human Hepatotoxic Potentials?Toxicologic Pathology, 33
(2005)
Recent advances in pharmacoTable 3: continued Countrya Descriptionb Yearc Numberd Ref.e Wheref Notes UK Proportion of in vivo
W. Chiou, P. Buehler (2002)
Comparison of Oral Absorption and Bioavailability of Drugs Between Monkey and HumanPharmaceutical Research, 19
K. Bischoff, R. Dedrick (1968)
Thiopental pharmacokinetics.Journal of pharmaceutical sciences, 57 8
Y. Shitara, T. Horie, Y. Sugiyama (2006)
Transporters as a determinant of drug clearance and tissue distribution.European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 27 5
L. Harrison, M. Gibaldi (1977)
Physiologically based pharmacokinetic model for digoxin distribution and elimination in the rat.Journal of pharmaceutical sciences, 66 8
I. Nestorov (2003)
Whole Body Pharmacokinetic ModelsClinical Pharmacokinetics, 42
Ronald Brown, M. Delp, S. Lindstedt, L. Rhomberg, R. Beliles (1997)
Physiological Parameter Values for Physiologically Based Pharmacokinetic ModelsToxicology and Industrial Health, 13
T. Rodgers, D. Leahy, M. Rowland (2005)
Physiologically based pharmacokinetic modeling 1: predicting the tissue distribution of moderate-to-strong bases.Journal of pharmaceutical sciences, 94 6
Lester Harrison, Milo Gibaldi (1977)
Physiologically based pharmacokinetic model for digoxin disposition in dogs and its preliminary application to humans.Journal of pharmaceutical sciences, 66 12
Huadong Tang, M. Mayersohn (2006)
A global examination of allometric scaling for predicting human drug clearance and the prediction of large vertical allometry.Journal of pharmaceutical sciences, 95 8
Hong Wan, A. Holmén, M. Någård, W. Lindberg (2002)
Rapid screening of pKa values of pharmaceuticals by pressure-assisted capillary electrophoresis combined with short-end injection.Journal of chromatography. A, 979 1-2
Akira Tsuji, K. Nishide, H. Minami, Emi Nakashima, Tetsuya Terasaki, T. Yamana (1985)
Physiologically based pharmacokinetic model for cefazolin in rabbits and its preliminary extrapolation to man.Drug metabolism and disposition: the biological fate of chemicals, 13 6
E. Bradshaw-Pierce, S. Eckhardt, Daniel Gustafson, Daniel Gustafson (2007)
A Physiologically Based Pharmacokinetic Model of Docetaxel Disposition: from Mouse to ManClinical Cancer Research, 13
H. Jones, N. Parrott, K. Jorga, T. Lavé (2006)
A Novel Strategy for Physiologically Based Predictions of Human PharmacokineticsClinical Pharmacokinetics, 45
E. Marrer, F. Dieterle (2007)
Promises of Biomarkers in Drug Development – A Reality CheckChemical Biology & Drug Design, 69
P. Poulin, Kerstin Schoenlein, F. Theil (2001)
Prediction of adipose tissue: plasma partition coefficients for structurally unrelated drugs.Journal of pharmaceutical sciences, 90 4
Chuck Timchalk, R. Nolan, A. Mendrala, D. Dittenber, K. Brzak, Joel Mattsson (2002)
A Physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) model for the organophosphate insecticide chlorpyrifos in rats and humans.Toxicological sciences : an official journal of the Society of Toxicology, 66 1
J. Gearhart, G. Jepson, H. Clewell, M. Andersen, R. Conolly (1990)
Physiologically based pharmacokinetic and pharmacodynamic model for the inhibition of acetylcholinesterase by diisopropylfluorophosphate.Toxicology and applied pharmacology, 106 2
J. Gearhart, G. Jepson, H. Clewell, M. Andersen, R. Conolly (1990)
Physiologically based pharmacokinetic and pharmacodynamic model for the inhibition of acetylcholinesterase by diisopropyfluorophosphateToxicology and Applied Pharmacology, 106
A. Tsuji, T. Yoshikawa, K. Nishide, H. Minami, M. Kimura, E. Nakashima, T. Terasaki, E. Miyamoto, C. Nightingale, T. Yamana (1983)
Physiologically based pharmacokinetic model for beta-lactam antibiotics I: Tissue distribution and elimination in rats.Journal of pharmaceutical sciences, 72 11
W. Chiou, Hyunyoung Jeong, Sang Chung, Ta-Chen Wu (2000)
Evaluation of Using Dog as an Animal Model to Study the Fraction of Oral Dose Absorbed of 43 Drugs in HumansPharmaceutical Research, 17
T. Kennedy (1997)
Managing the drug discovery/development interfaceDrug Discovery Today, 2
Simon Thomas (2008)
Clinical relevance of predictive physiologically based pharmacokinetic methodsExpert Opinion on Drug Discovery, 3
P. Graaf, E. Schaick, S. Visser, H. Greef, A. IJzerman, M. Danhof (1999)
Mechanism-based pharmacokinetic-pharmacodynamic modeling of antilipolytic effects of adenosine A(1) receptor agonists in rats: prediction of tissue-dependent efficacy in vivo.The Journal of pharmacology and experimental therapeutics, 290 2
S. Peters, A. Ungell, H. Dolgos (2009)
Physiologically based pharmacokinetic (PBPK) modeling and simulation: applications in lead optimization.Current opinion in drug discovery & development, 12 4
Vera Fiserova-Bergerova (1992)
Inhalation anesthesia using physiologically based pharmacokinetic models.Drug metabolism reviews, 24 4
T. Poet, A. Kousba, S. Dennison, Chuck Timchalk (2004)
Physiologically based pharmacokinetic/pharmacodynamic model for the organophosphorus pesticide diazinon.Neurotoxicology, 25 6
I. Mahmood (2002)
Prediction of Clearance in Humans from In Vitro Human Liver Microsomes and Allometric Scaling. A Comparative Study of the Two ApproachesDrug Metabolism and Drug Interactions, 19
M. Andersen, H. Clewell, M. Gargas, F. Smith, R. Reitz (1987)
Physiologically based pharmacokinetics and the risk assessment process for methylene chloride.Toxicology and applied pharmacology, 87 2
H. Olson, G. Betton, D. Robinson, K. Thomas, A. Monro, G. Kolaja, P. Lilly, James Sanders, Glenn Sipes, W. Bracken, M. Dorato, Koen Deun, Peter Smith, B. Berger, Allen Heller (2000)
Concordance of the toxicity of pharmaceuticals in humans and in animals.Regulatory toxicology and pharmacology : RTP, 32 1
A. Tsuji, T. Yoshikawa, K. Nishide, H. Minami, M. Kimura, E. Nakashima, T. Terasaki, E. Miyamoto, C. Nightingale, T. Yamana (1983)
Physiologically Based Pharmacokinetic Model for β-Lactam Antibiotics I: Tissue Distribution and Elimanation RatesJournal of Pharmaceutical Sciences, 72
B. Sikic (2018)
Antineoplastic agentsReactions Weekly, 1726
I. Kola, John Landis (2004)
Can the pharmaceutical industry reduce attrition rates?Nature Reviews Drug Discovery, 3
Y. Igari, Y. Sugiyama, Y. Sawada, T. Iga, M. Hanano (1983)
Prediction of diazepam disposition in the rat and man by a physiologically based pharmacokinetic modelJournal of Pharmacokinetics and Biopharmaceutics, 11
I. Poggesi (2004)
Predicting human pharmacokinetics from preclinical data.Current opinion in drug discovery & development, 7 1
K. Yokogawa, E. Nakashima, J. Ishizaki, H. Maeda, T. Nagano, F. Ichimura (1990)
Relationships in the Structure–Tissue Distribution of Basic Drugs in the RabbitPharmaceutical Research, 7
T. Rodgers, M. Rowland (2006)
Physiologically based pharmacokinetic modelling 2: predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions.Journal of pharmaceutical sciences, 95 6
W. Chiu, H. Barton, R. Dewoskin, P. Schlosser, C. Thompson, B. Sonawane, J. Lipscomb, K. Krishnan (2007)
Evaluation of physiologically based pharmacokinetic models for use in risk assessmentJournal of Applied Toxicology, 27
K. Ward, B. Smith (2004)
A comprehensive quantitative and qualitative evaluation of extrapolation of intravenous pharmacokinetic parameters from rat, dog, and monkey to humans. II. Volume of distribution and mean residence time.Drug metabolism and disposition: the biological fate of chemicals, 32 6
M. Tomita (2001)
Whole-cell simulation: a grand challenge of the 21st century.Trends in biotechnology, 19 6
F. Brightman, D. Leahy, G. Searle, Simon Thomas (2006)
APPLICATION OF A GENERIC PHYSIOLOGICALLY BASED PHARMACOKINETIC MODEL TO THE ESTIMATION OF XENOBIOTIC LEVELS IN RAT PLASMADrug Metabolism and Disposition, 34
T. Lavé, N. Parrott, H. Grimm, A. Fleury, M. Reddy (2007)
Challenges and opportunities with modelling and simulation in drug discovery and drug developmentXenobiotica, 37
F. Brightman, D. Leahy, G. Searle, S. Thomas (2006)
APPLICATION OF A GENERIC PHYSIOLOGICALLY BASED PHARMACOKINETIC MODEL TO THE ESTIMATION OF XENOBIOTIC LEVELS IN HUMAN PLASMADrug Metabolism and Disposition, 34
K. Ward (2005)
Recent advances in pharmacokinetic extrapolation from preclinical data to humansExpert Opinion on Drug Metabolism & Toxicology, 1
S. Buck, Vikash Sinha, L. Fenu, M. Nijsen, C. Mackie, R. Gilissen (2007)
Prediction of Human Pharmacokinetics Using Physiologically Based Modeling: A Retrospective Analysis of 26 Clinically Tested DrugsDrug Metabolism and Disposition, 35
R. Jackson (1984)
A kinetic model of regulation of the deoxyribonucleoside triphosphate pool composition.Pharmacology & therapeutics, 24 2
H. Jones, I. Gardner, Kenny Watson (2009)
Modelling and PBPK Simulation in Drug DiscoveryThe AAPS Journal, 11
P. Poulin, F. Theil (2002)
Prediction of pharmacokinetics prior to in vivo studies. 1. Mechanism-based prediction of volume of distribution.Journal of pharmaceutical sciences, 91 1
J. Valentin (2002)
Basic anatomical and physiological data for use in radiological protection: reference valuesAnnals of the ICRP, 32
Katy Taylor, N. Gordon, G. Langley, W. Higgins (2008)
Estimates for Worldwide Laboratory Animal Use in 2005Alternatives to Laboratory Animals, 36
R. Dedrick, D. Forrester, D. Ho (1972)
In vitro-in vivo correlation of drug metabolism--deamination of 1- -D-arabinofuranosylcytosine.Biochemical pharmacology, 21 1
S. Willmann, Karsten Höhn, A. Edginton, M. Sevestre, Juri Solodenko, Wolfgang Weiss, J. Lippert, W. Schmitt (2007)
Development of a Physiology-Based Whole-Body Population Model for Assessing the Influence of Individual Variability on the Pharmacokinetics of DrugsJournal of Pharmacokinetics and Pharmacodynamics, 34
C. Chassagnole, R. Jackson, N. Hussain, L. Bashir, C. Derow, J. Savin, D. Fell (2006)
Using a mammalian cell cycle simulation to interpret differential kinase inhibition in anti-tumour pharmaceutical development.Bio Systems, 83 2-3
D. Hallifax, J. Houston (2009)
Methodological uncertainty in quantitative prediction of human hepatic clearance from in vitro experimental systems.Current drug metabolism, 10 3
W. Chiou, A. Barve (1998)
Linear Correlation of the Fraction of Oral Dose Absorbed of 64 Drugs Between Humans and RatsPharmaceutical Research, 15
The global pharmaceutical industry is estimated to use close to 20 million animals annually, in in vivo studies which apply the results of fundamental biomedical research to the discovery and development of novel pharmaceuticals, or to the application of existing pharmaceuticals to novel therapeutic indications. These applications of in vivo experimentation include: a) the use of animals as disease models against which the efficacy of therapeutics can be tested; b) the study of the toxicity of those therapeutics, before they are administered to humans for the first time; and c) the study of their pharmacokinetics —i.e. their distribution throughout, and elimination from, the body. In vivo pharmacokinetic (PK) studies are estimated to use several hundred thousand animals annually. The success of pharmaceutical research currently relies heavily on the ability to extrapolate from data obtained in such in vivo studies to predict therapeutic behaviour in humans. Physiologically-based modelling has the potential to reduce the number of in vivo animal studies that are performed by the pharmaceutical industry. In particular, the technique of physiologically-based pharmacokinetic (PBPK) modelling is sufficiently developed to serve as a replacement for many in vivo PK studies in animals during drug discovery. Extension of the technique to incorporate the prediction of in vivo therapeutic effects and/or toxicity is less well-developed, but has potential in the longer-term to effect a significant reduction in animal use, and also to lead to improvements in drug discovery via the increased rationalisation of lead optimisation.
Alternatives to Laboratory Animals – SAGE
Published: Nov 1, 2009
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.